Head to head
Helmerich & Payne vs Noble
Side-by-side on the measures that matter, with a plain-English read. Full detail: HP · NE
HP
Helmerich & Payne
31.77-2.07%
1-year price shape — +35% over the period
Quant Rating D · 77/100
vs
NE
Noble
36.72-2.83%
1-year price shape — +31% over the period
Quant Rating D · 74/100
1-year performance, rebased to 100
Helmerich & Payne edges it on the scoreable measures. Helmerich & Payne has the highest Quant Rating (77); Helmerich & Payne has done best over the past year (+35%).
| HP | NE | |
|---|---|---|
| Snapshot | ||
| Sector | Oil & Gas Drilling | -- |
| Last price | 31.77 | 36.72 |
| Change today | -2.07% | -2.83% |
| 1-year return | +35.0% | +30.9% |
| Market cap | $3.18B | $5.86B |
| 52-week range | 25.44 – 47.84 | 26.79 – 53.83 |
| Valuation | ||
| P/E (TTM) | -5.55 | 108.00 |
| P/E percentile, own 5-yr range | 18th | 99th |
| P/B | 1.52 | 1.37 |
| Dividend yield | 3.15% | 5.45% |
| Profitability & growth | ||
| EPS (TTM) | -5.72 | 1.35 |
| Net profit (TTM) | $-571.81M | $215.54M |
| Revenue (TTM) | $4.00B | $3.00B |
| Provider revenue period date | 2026-06-29 | 2026-09-29 |
| Revenue growth (YoY) | -0.6% | -8.7% |
| Gross margin | 13.5% | 15.1% |
| Operating margin | 3.0% | 11.3% |
| Net margin | -3.5% | 1.8% |
| Free cash flow (TTM) | $315.29M | $96.93M |
| Provider cash-flow period date | 2026-06-29 | 2026-09-29 |
| Ownership & sentiment | ||
| Institutional ownership | 105.8% | 86.6% |
| Insider activity (12mo) | 22 buy / 27 sell | 19 buy / 31 sell |
| Short interest (% of float) | 6.5% | 8.8% |
| Analyst consensus | 56% buy / 33% hold / 11% sell (9) | 20% buy / 80% hold (5) |
| Analyst price target | $46 (+45%) | $51 (+38%) |
| StockVane view | ||
| StockVane Quant Rating | D (77) | D (74) |
| Company | ||
| Employees | 15,700 | 4,500 |
| Founded | 1940 | 1921 |
▲ marks the more favourable stock(s) on measures with a clear direction (lower P/E, higher yield, higher Quant Rating, better 1-year return). Analyst consensus counts each covering institution once, at its most recent rating. Not a recommendation. Quant Rating method: Data & Methodology.